Search Results - "Katarina Zevnik"

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers by Skoblar Vidmar, Marija, Doma, Andrej, Smrdel, Uroš, Zevnik, Katarina, Studen, Andrej

“…The evaluation of treatment response remains a challenge in glioma cases because the neuro oncological therapy can lead to the development of treatment-related…”
Get full text

Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study by Hribernik, Nežka, Huff, Daniel T, Studen, Andrej, Zevnik, Katarina, Klaneček, Žan, Emamekhoo, Hamid, Škalic, Katja, Jeraj, Robert, Reberšek, Martina

“…Purpose To develop quantitative molecular imaging biomarkers of immune-related adverse event (irAE) development in malignant melanoma (MM) patients receiving…”
Get full text

Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre 18F-FDG PET/CT and bone marrow biopsy evaluation study by Doma, Andrej, Zevnik, Katarina, Studen, Andrej, Prevodnik, Veronika Kloboves, Gasljevic, Gorana, Novakovic, Barbara Jezersek

“…Detection of bone marrow involvement (BMI) in diffuse large B-cell lymphoma (DLBCL) typically relies on invasive bone marrow biopsy (BMB) that faces procedure…”
Get full text

Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study by Hribernik, Nezka, Strasek, Katja, Huff, Daniel T, Studen, Andrej, Zevnik, Katarina, Skalic, Katja, Jeraj, Robert, Rebersek, Martina

“…To evaluate the role of the novel quantitative imaging biomarker (QIB) SUV of F-FDG uptake extracted from early F-FDG-PET/CT scan at 4 weeks for the detection…”
Get full text

CDKN2A-positive melanoma patient treated with combination immunotherapy – A case report by Zevnik, Katarina, Blatnik, Ana, Novaković, Srdjan, Hribernik, Nežka

“…Germline aberrations in the CDKN2A gene are observed in 20%–40% of families susceptible to melanoma. Positive CDKN2A status is associated with early age of…”
Get full text

Updated recommendations for the diagnosis and treatment of differentiated thyroid cancer by Nikola Bešić, Alenka Grošel, Andraž Perhavec, Andrej Doma, Andreja Schwarzbartl-Pevec, Andreja Klevišar Ivančič, Andrej Vogrin, Barbara Vidergar-Kralj, Barbara Gazić, Barbara Perić, Blaž Krhin, Cvetka Grašič Kuhar, Edvard Pirnat, Ivana Žagar, Jerca Blazina, Katarina Zevnik, Katica Bajuk Studen, Katja Zaletel, Margareta Strojan Fležar, Marko Hočevar, Marko Kokalj, Marta Dremelj, Nebojša Glumac, Olga Blatnik, Simona Gaberšček, Snežana Pavlović Đokić, Ulrika Klopčič, Veronika Kloboves-Prevodnik, Zorica Čekić

Get full text

Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre 18 F-FDG PET/CT and bone marrow biopsy evaluation study by Doma, Andrej, Zevnik, Katarina, Studen, Andrej, Prevodnik, Veronika Kloboves, Gasljevic, Gorana, Novakovic, Barbara Jezersek

“…Detection of bone marrow involvement (BMI) in diffuse large B-cell lymphoma (DLBCL) typically relies on invasive bone marrow biopsy (BMB) that faces procedure…”
Get full text

Priporočila za obravnavo bolnikov z melanomom kože by Martina Reberšek, Janja Ocvirk, Primož Strojan, Barbara Perić, Marko Hočevar, Katarina Šmuc Berger, Vesna Zadnik, Olga Blatnik, Katarina Zevnik, Nina Boc, Nežka Hribernik, Tanja Mesti, Karla Berlec, Nada Kozjek Rotovnik, Maja Ebert Moltara, Jernej Benedik, Boštjan Luzar, Jože Pižem, Marko Boc, Marija Ignjatović, Katarina Karner, Gaber Plavc, Marko Kokalj, Marko Snoj, Katarina Trčko

“…Incidenca melanoma v svetu in Sloveniji še vedno narašča, se je pa preživetje v zadnjih 20 letih izboljšalo, predvsem zaradi zgodnejšega odkrivanja melanoma in…”
Get full text